spec sheet10 rows
ALD-52 (1-acetyl-LSD) is the 1-acetyl derivative of LSD, historically associated with the "Orange Sunshine" acid of the 1960s and one of the earliest known N-acylated lysergamides. Although 1-acyl substitution reduces affinity and efficacy at the 5-HT2A receptor by one to two orders of magnitude relative to LSD, pharmacological studies show that ALD-52 is rapidly and efficiently deacetylated in vivo to yield high plasma concentrations of LSD, supporting its classification as a prodrug. Consistent with this, it induces the 5-HT2A-mediated head-twitch response in mice with relatively high potency and produces a classic serotonergic psychedelic experience in humans of roughly LSD-like strength. It has re-emerged as a research chemical alongside related acyl derivatives such as 1P-LSD and 1cP-LSD, and in silico toxicology work has begun to profile its potential genotoxic and cardiopulmonary liabilities.
- Very LSD-like experience
- Long duration
- Sometimes described as slightly softer
- Rapidly deacetylated to LSD as a prodrug
- Anxiety in the wrong setting
- Vasoconstriction
- Insomnia after use
Mechanism
The active molecule works chiefly as a partial at the receptor, the main driver of the psychedelic state, with additional activity at 5-HT2C, , and receptors. The small 1-acetyl group is thought to be cleaved after dosing to release LSD, so ALD-52 behaves like a carrier form of LSD. It is generally reported as very close to LSD in effect, sometimes described as slightly softer.
receptor fingerprint
receptorpartial agonist (via LSD)
5-HT2C receptoragonist
receptorpartial agonist
Safetyrisks and cautions, not medical advice
ALD-52 is generally reported as near-LSD in strength and character, but it remains a research chemical without formal safety data. Avoid with a personal or family history of psychosis or bipolar disorder, and never combine lysergamides with MAOIs or strongly serotonergic drugs (serotonin toxicity), or with lithium or tramadol (seizure reports). Not medical advice.
Subjective profileweighing the evidence above
Functionally LSD with an extra acetyl group the body strips off, so the experience and the risks are essentially LSD's. That means little reason to seek it out on its own merits, no formal safety data behind it, and an absolute no with any psychosis or bipolar history.
Resources
This entry is here for reference.
Research
- 2016first citedReturn of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-…
- 2026most recentThe toxicity of psychedelic LSD derivatives: 1-acetyl-LSD (ALD-52), 1-propionyl-LSD (1P-LSD), 1…
- 1.Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD).
- 2.Analytical and Pharmacological Characterization of 1-(Furan-2-Carbonyl)-LSD (1F-LSD) and Comparison With 1-(Thiophene-2-Carbonyl)-LSD (1T-LSD).
- 3.In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures.
- 4.The toxicity of psychedelic LSD derivatives: 1-acetyl-LSD (ALD-52), 1-propionyl-LSD (1P-LSD), 1-butyryl-LSD (1B-LSD), 1-valeryl-LSD (1V-LSD) and 1-cyclopropylmethanoyl-LSD (1cP-LSD)-prediction of toxicological parameters relevant to clinical and forensic toxicology using multi-in silico approach.
- 5.Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD).
- 6.Forensic Aspects of Designer LSD Analogs Identification by GC-MS (EI) and UV Spectroscopy.
6 listed here; entry last updated August 2026
Reviews
My notesprivate to this device
FAQ
Is ALD-52 the original Orange Sunshine?
The famous Orange Sunshine is historically associated with ALD-52, though what was actually distributed varied.
How does it compare to LSD?
It is thought to convert to LSD and is generally reported as very close, occasionally described as a bit gentler.
Is it legal?
Legal status varies by country and changes often; check your local laws. This is not medical advice.
Limitations of the evidence
- No formal safety data
Adverse effects
- Anxiety in the wrong setting
- Vasoconstriction
- Insomnia after use